Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridineFLYNN, D. D; MASH, D. C.The Journal of pharmacology and experimental therapeutics. 1989, Vol 250, Num 2, pp 573-581, issn 0022-3565Article

Characterization of L-[³H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normalFLYNN, D. D; MASH, D. C.Journal of neurochemistry. 1986, Vol 47, Num 6, pp 1948-1954, issn 0022-3042Article

Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease : implications for the failure of cholinergic replacement therapiesFLYNN, D. D; WEINSTEIN, D. A; MASH, D. C et al.Annals of neurology. 1991, Vol 29, Num 3, pp 256-262, issn 0364-5134, 7 p.Article

Characterization and distribution of transferrin receptors in the rat brainMASH, D. C; PABLO, J; FLYNN, D. D et al.Journal of neurochemistry. 1990, Vol 55, Num 6, pp 1972-1979, issn 0022-3042, 8 p.Article

Different effects of N-ethylmaleimide on M1 and M2 muscarine receptors in rat brainFLYNN, D. D; POTTER, L. T.Proceedings of the National Academy of Sciences of the United States of America. 1985, Vol 82, Num 2, pp 580-583, issn 0027-8424Article

Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer' diseaseFLYNN, D. D; FERRARI-DILEO, G; MASH, D. C et al.Journal of neurochemistry. 1995, Vol 64, Num 4, pp 1888-1891, issn 0022-3042Article

Interactions of cocaine with primary and secondary recognition sites on muscarinic receptorsFLYNN, D. D; VAISHNAV, A. A; MASH, D. C et al.Molecular pharmacology. 1992, Vol 41, Num 4, pp 736-742, issn 0026-895XArticle

Potential application of radiolabeled ligand studies of dementing diseases by positron emission tomographyMASH, D. C; FLYNN, D. D.Frontiers of clinical neuroscience. 1990, Vol 10, pp 149-160, issn 0887-3658, 12 p.Article

Pharmacological screen for activities of 12-hydroxyibogamine : a primary metabolite of the indole alkaloid ibogaineSTALEY, J. K; OUYANG, Q; PABLO, J et al.Psychopharmacologia. 1996, Vol 127, Num 1, pp 10-18, issn 0033-3158Article

Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [¹²⁵I]RTI-55 : in vitro binding and autoradiographic characterizationSTALEY, J. K; BASILE, M; FLYNN, D. D et al.Journal of neurochemistry. 1994, Vol 62, Num 2, pp 549-556, issn 0022-3042Article

Perinatal cocaine exposure alters sigma binding site density in the placentaFLYNN, D. D; SANCHEZ-RAMOS, L; MASH, D. C et al.Research communications in substance abuse. 1993, Vol 14, Num 1, pp 17-36, issn 0193-0818Article

Pharmacological strategies to selectively label and localize muscarinic receptor subtypesFLYNN, D. D; REEVER, C. M; FERRARI-DILEO, G et al.Drug development research. 1997, Vol 40, Num 2, pp 104-116, issn 0272-4391Article

Diminished muscarinic receptor-stimulated [³H]-PIP₂ hydrolysis in Alzheimer's diseaseFERRARI-DILEO, G; FLYNN, D. D.Life sciences (1973). 1993, Vol 53, Num 25, pp PL.439-PL.444, issn 0024-3205Article

Cocaethylene : a unique cocaine metabolite displays high affinity for the dopamine transporterHEARN, W. L; FLYNN, D. D; HIME, G. W et al.Journal of neurochemistry. 1991, Vol 56, Num 2, pp 698-701, issn 0022-3042, 4 p.Article

Effect of solubilization on the distinct binding properties of muscarine receptors from rabbit hippocampus and brainstemFLYNN, D. D; POTTER, L. T.Molecular pharmacology. 1986, Vol 30, Num 3, pp 193-199, issn 0026-895XArticle

Agonist binding to M₁ muscarinic receptors is sensitive to guanine nucleotidesFLYNN, D. D; PALERMO, N; SUAREZ, A et al.European journal of pharmacology. Molecular pharmacology section. 1989, Vol 172, Num 4-5, pp 363-372, issn 0922-4106Article

Polyclonal anti-propylbenzilylcholine mustard antibodies selectively recognize labeled muscarinic receptors from rabbit brainSTRANG, P. F; FLYNN, D. D.Neuroscience letters. 1989, Vol 104, Num 1-2, pp 201-208, issn 0304-3940Article

Effect of solubilization on the distinct binding properties of muscarine receptors from rabbit hippocampus and brainstemFLYNN, D. D; POTTER, L. T.Molecular pharmacology. 1986, Vol 30, Num 3, pp 193-199, issn 0026-895XArticle

Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervationMASH, D. C; FLYNN, D. D; POTTER, L. T et al.Science (Washington, D.C.). 1985, Vol 228, Num 4703, pp 1115-1117, issn 0036-8075Article